Controlled Shutdown Operations is a systematic framework within process shutdown dynamics that orchestrates the sequential, safe, and predictable de-energization of system components to minimize operational disruptions, safety risks, and equipment damage during planned or emergency cessation of operations.
2
Publications
115
Citations
18
Authors
10
Institutions
Publications per year
2017–2026
1
Parents
Publications
2
Ahmad Almaya, Lawrence De Belder, Robert Meyer et al. · Journal of Pharmaceutical Sciences · 2017 · 64 citations
Pharmacy, Pharmacy Practice, Pharmaceutical Manufacturing +10
1–2 of 2
Authors
18
- HH
1
h-index
- TK
1
h-index
- TS
1
h-index
- JJ
1
h-index
- DB
1
h-index
1–5 of 18
Institutions
10
Bristol-Myers Squibb (United States)
New York, United States
1 h-index
2 publications
128 citations
Eli Lilly (United States)
Indianapolis, United States
1 h-index
2 publications
128 citations
AbbVie (United States)
North Chicago, United States
1 h-index
1 publications
64 citations
Amgen (United States)
Thousand Oaks, United States
1 h-index
1 publications
64 citations
Kyoto University
Kyoto, Japan
1 h-index
1 publications
51 citations
Janssen (Belgium)
Beerse, Belgium
1 h-index
1 publications
64 citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
1 h-index
2 publications
128 citations
Pfizer (United States)
New York, United States
1 h-index
1 publications
64 citations
1–8 of 10
Venues
- Applied Catalysis A General
1 publications · 51 citations
1
h-index
- Journal of Pharmaceutical Sciences
1 publications · 64 citations
1
h-index
1–2